Thermo Fisher beats by $0.12, beats on revs, increases quarterly dividend to $0.17/share from $0.15/share; co will provide 2018 guidance on call (214.62)
Reports Q4 (Dec) earnings of $2.79 per share, excluding non-recurring items, $0.12 better than the Capital IQ Consensus of $2.67; revenues rose 22.1% year/year to $6.05 bln vs the $5.72 bln Capital IQ Consensus.
In the fourth quarter of 2017, Life Sciences Solutions Segment revenue grew 11% to $1.58 billion, compared with revenue of $1.42 billion in the fourth quarter of 2016.
Results for the Analytical Instruments Segment reflect the acquisition of FEI Company in September 2016. Segment revenue grew 16% to $1.41 billion in the fourth quarter of 2017, compared with revenue of $1.22 billion in the fourth quarter of 2016.
Laboratory Products and Services Segment results reflect the acquisition of Patheon in late August 2017. In the fourth quarter of 2017, segment revenue grew 43% to $2.40 billion, compared with revenue of $1.68 billion in the fourth quarter of 2016